Literature DB >> 25841551

Mast cell activation syndromes presenting as anaphylaxis.

Cem Akin1.   

Abstract

Anaphylaxis results from severe systemic mast cell activation. In addition to IgE-mediated and physical triggers, it may occur with a clonal mast cell disease and in an idiopathic fashion without clear provoking factors. Disorders of mast cell activation are classified into primary (clonal), secondary, and idiopathic. Mast cell activation syndrome (MCAS) is a multisystem disorder characterized by objective documentation of elevated mast cell mediators during attacks and a favorable response to antimediator therapy. It should be considered in the differential diagnosis of patients presenting with recurrent anaphylaxis without a clear cause. This article discusses the diagnosis of MCAS.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anaphylaxis; Mast cell activation syndrome; Mast cells; Mastocytosis; Tryptase

Mesh:

Substances:

Year:  2015        PMID: 25841551     DOI: 10.1016/j.iac.2015.01.010

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  16 in total

Review 1.  Mast Cells and Anaphylaxis.

Authors:  Phil Lieberman; Lene Heise Garvey
Journal:  Curr Allergy Asthma Rep       Date:  2016-03       Impact factor: 4.806

Review 2.  Anaphylaxis.

Authors:  Daniel LoVerde; Onyinye I Iweala; Ariana Eginli; Guha Krishnaswamy
Journal:  Chest       Date:  2017-08-08       Impact factor: 9.410

Review 3.  Mast cell-neural interactions contribute to pain and itch.

Authors:  Kalpna Gupta; Ilkka T Harvima
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

Review 4.  The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives.

Authors:  Peter Valent; Joanna N G Oude Elberink; Aleksandra Gorska; Magdalena Lange; Roberta Zanotti; Björn van Anrooij; Massimiliano Bonifacio; Patrizia Bonadonna; Karoline V Gleixner; Emir Hadzijusufovic; Cecelia Perkins; Karin Hartmann; Anja Illerhaus; Serena Merante; Chiara Elena; Khalid Shoumariyeh; Nikolas von Bubnoff; Roberta Parente; Massimo Triggiani; Juliana Schwaab; Mohamad Jawhar; Francesca Caroppo; Anna Belloni Fortina; Knut Brockow; Rosemarie Greul; Akif Selim Yavuz; Michael Doubek; Mattias Mattsson; Hans Hagglund; Jens Panse; Vito Sabato; Elisabeth Aberer; Haifa Kathrin Al-Ali; Marie-Anne Morren; Judit Varkonyi; Alexander Zink; Marek Niedoszytko; Dietger Niederwieser; Luca Malcovati; Andreas Reiter; Vanessa Kennedy; Jason Gotlib; Olivier Lortholary; Olivier Hermine; Michel Arock; Hanneke Kluin-Nelemans; Wolfgang R Sperr
Journal:  J Allergy Clin Immunol Pract       Date:  2018-11-08

5.  Mast cell tryptase and carboxypeptidase A expression in body fluid and gastrointestinal tract associated with drug-related fatal anaphylaxis.

Authors:  Xiang-Jie Guo; Ying-Yuan Wang; Hao-Yue Zhang; Qian-Qian Jin; Cai-Rong Gao
Journal:  World J Gastroenterol       Date:  2015-12-21       Impact factor: 5.742

Review 6.  Evaluation and Classification of Mast Cell Disorders: A Difficult to Manage Pathology in Clinical Practice.

Authors:  Polliana Mihaela Leru
Journal:  Cureus       Date:  2022-02-13

Review 7.  Nonclonal Mast Cell Activation Syndrome: A Growing Body of Evidence.

Authors:  Matthew J Hamilton
Journal:  Immunol Allergy Clin North Am       Date:  2018-06-09       Impact factor: 3.479

8.  Anaphylactic shock during cement implantation of a total hip arthroplasty in a patient with underlying mastocytosis: case report of a rare intraoperative complication.

Authors:  Anita Ten Hagen; Pieter Doldersum; Tom van Raaij
Journal:  Patient Saf Surg       Date:  2016-11-05

9.  Blockade of STAT3 in T Cells Inhibits Germinal Center Reactions against Intranasal Allergens.

Authors:  Garam Choi; Yeonseok Chung
Journal:  Biomol Ther (Seoul)       Date:  2016-05-01       Impact factor: 4.634

10.  A novel combination of an IgE mediated adult onset food allergy and a suspected mast cell activation syndrome presenting as anaphylaxis.

Authors:  Colin Barber; Chrystyna Kalicinsky
Journal:  Allergy Asthma Clin Immunol       Date:  2016-09-17       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.